FDA Inspection 1206283 — Seqirus Vaccines Limited
The FDA completed an inspection of Seqirus Vaccines Limited on May 26, 2023 in Liverpool. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 26, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Liverpool (United Kingdom)